Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways

SIMPLE SUMMARY: Pulmonary sarcomatoid carcinoma (PSC) is an aggressive subtype of non-small-cell lung cancer (NSCLC). It does not respond favorably to standard chemotherapy, and the response to PD-1/PD-L1 inhibitors remains modest. The introduction of new therapeutic approaches for this subtype is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Cali Daylan, Ayse Ece, Deng, Lei, Yang, Jihua, Sharma, Janaki, Su, Christopher, Li, Shenduo, Zang, Xingxing, Halmos, Balazs, Borczuk, Alain, Cheng, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340395/
https://www.ncbi.nlm.nih.gov/pubmed/37444481
http://dx.doi.org/10.3390/cancers15133372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340395/
https://www.ncbi.nlm.nih.gov/pubmed/37444481
http://dx.doi.org/10.3390/cancers15133372

Ejemplares similares